GSH neutralizes oxidative stress (fatigue/fog/inflammation). Low = all chronic ills; supp = energy/skin ↑.

Low GSH Signs

  • Skin/heart/muscle pain/fatigue/fog/memory/BP/aging/DM/autoimmune/neuro/fibro/allergies/lungs/cancer/GI.

Linked: Aging/obesity/stress/sleep/alcohol/smoke/toxins/sedentary/abx/NSAIDs.

Cellular Wins

  • Regens Vit C/E/lutein.

  • Liver detox/cancer/neuro ↓.

  • Mitochondria energy/digestion ↑.

  • Almonds: Blood GSH +16%, smoke damage -29% (PubMed 18029489).

Made From: Cysteine/glycine/glutamate (liver).

Optimal: 440-654 mcg/dL blood.

Boost Tables

Foods (Direct/Sulfur)

Direct GSHSulfur-Rich
Mushrooms, avocado, spinach, okraEggs, grass-fed (beef post), organs, sardines, salmon, garlic/onion/ginger, crucifers, honey (honey post), almonds
 

Supps (Precursors/Direct)

TypeExamples
PrecursorsNAC, glycine, Vit C, B6, B12, folate
Direct (Absorbable)S-acetyl/liposomal (100-1000mg/day)
 

Therapeutic Dosing

  • NAFLD/DM/PCOS/Psoriasis/Eczema/Autoimmune (Crohn/Hashi/Lupus)/Neuro/Parkinson/Nerve/Lungs: 250-500mg liposomal daily.

  • Clinics: Fatigue/skin/energy ↑; sulfur-sensitive skip.

Master protector—eat/supps for vitality.


References:

  1. Glutathione for fatty liver: Honda Y, Kessoku T, Sumida Y, Kobayashi T, Kato T, Ogawa Y, Tomeno W, Imajo K, Fujita K, Yoneda M, Kataoka K, Taguri M, Yamanaka T, Seko Y, Tanaka S, Saito S, Ono M, Oeda S, Eguchi Y, Aoi W, Sato K, Itoh Y, Nakajima A. Efficacy of glutathione for the treatment of nonalcoholic fatty liver disease: an open-label, single-arm, multicenter, pilot study. BMC Gastroenterol. 2017 Aug 8;17(1):96. doi: 10.1186/s12876-017-0652-3. PMID: 28789631; PMCID: PMC5549431. https://pmc.ncbi.nlm.nih.gov/articles/PMC5549431/
  2. Santacroce G, Gentile A, Soriano S, Novelli A, Lenti MV, Di Sabatino A. Glutathione: Pharmacological aspects and implications for clinical use in non-alcoholic fatty liver disease. Front Med (Lausanne). 2023 Mar 22;10:1124275. doi: 10.3389/fmed.2023.1124275. PMID: 37035339; PMCID: PMC10075255.https://pmc.ncbi.nlm.nih.gov/articles/PMC10075255
  3. Glutathione improves insulin sensitivity: Søndergård SD, Cintin I, Kuhlman AB, Morville TH, Bergmann ML, Kjær LK, Poulsen HE, Giustarini D, Rossi R, Dela F, Helge JW, Larsen S. The effects of 3 weeks of oral glutathione supplementation on whole body insulin sensitivity in obese males with and without type 2 diabetes: a randomized trial. Appl Physiol Nutr Metab. 2021 Sep;46(9):1133-1142. doi: 10.1139/apnm-2020-1099. Epub 2021 Mar 19. PMID: 33740389. https://pubmed.ncbi.nlm.nih.gov/33740389/ 
  4. Low levels of glutathione in diabetes: Hakki Kalkan I, Suher M. The relationship between the level of glutathione, impairment of glucose metabolism and complications of diabetes mellitus. Pak J Med Sci. 2013 Jul;29(4):938-42. doi: 10.12669/pjms.294.2859. PMID: 24353663; PMCID: PMC3817774.
  5. Polycystic ovarian syndrome: Coşar A, Özcan P, Tanoglu FB, Tok OE, Özkara G, Timur HT, Çetin Ç, Neccar D. Comparative effects of the antioxidant glutathione with metformin and Diane-35 on hormonal, metabolic, and inflammatory indicators in a DHEA-induced PCOS rat model. Gynecol Endocrinol. 2024 Dec;40(1):2302086. doi: 10.1080/09513590.2024.2302086. Epub 2024 Jan 22. PMID: 38254321.  https://pubmed.ncbi.nlm.nih.gov/38254321/
  6. Fatigue Aoi W, Ogaya Y, Takami M, Konishi T, Sauchi Y, Park EY, Wada S, Sato K, Higashi A. Glutathione supplementation suppresses muscle fatigue induced by prolonged exercise via improved aerobic metabolism. J Int Soc Sports Nutr. 2015 Feb 6;12:7. doi: 10.1186/s12970-015-0067-x. PMID: 25685110; PMCID: PMC4328900. https://pubmed.ncbi.nlm.nih.gov/25685110/ 
  7. Medved I, Brown MJ, Bjorksten AR, Murphy KT, Petersen AC, Sostaric S, Gong X, McKenna MJ. N-acetylcysteine enhances muscle cysteine and glutathione availability and attenuates fatigue during prolonged exercise in endurance-trained individuals. J Appl Physiol (1985). 2004 Oct;97(4):1477-85. doi: 10.1152/japplphysiol.00371.2004. Epub 2004 Jun 11. PMID: 15194675.https://pubmed.ncbi.nlm.nih.gov/15194675/
  8. Psoriasis and eczema Chung J, Oh SY, Shin YK. Association of glutathione-S-transferase polymorphisms with atopic dermatitis risk in preschool age children. Clin Chem Lab Med. 2009;47(12):1475-81. doi: 10.1515/CCLM.2009.336. PMID: 19842992. https://pubmed.ncbi.nlm.nih.gov/19842992/
  9. Guarneri F, Sapienza D, Papaianni V, Marafioti I, Guarneri C, Mondello C, Roccuzzo S, Asmundo A, Cannavò SP. Association between genetic polymorphisms of glutathione S-transferase M1/T1 and psoriasis in a population from the area of the strict of messina (Southern Italy). Free Radic Res. 2020 Jan;54(1):57-63. doi: 10.1080/10715762.2019.1698738. Epub 2019 Dec 10. PMID: 31774007.https://pubmed.ncbi.nlm.nih.gov/31774007/
  10. Prussick R, Prussick L, Gutman J. Psoriasis Improvement in Patients Using Glutathione-enhancing, Nondenatured Whey Protein Isolate: A Pilot Study. J Clin Aesthet Dermatol. 2013 Oct;6(10):23-6. PMID: 24155989; PMCID: PMC3805302.https://pubmed.ncbi.nlm.nih.gov/24155989/
  11. Skin lightening Alzahrani TF, Alotaibi SM, Alzahrani AA, Alzahrani AF, Alturki LE, Alshammari MM, Alharbi RA, Alanazi SI, Alshammari WZ, Algarni AS. Exploring the Safety and Efficacy of Glutathione Supplementation for Skin Lightening: A Narrative Review. Cureus. 2025 Jan 27;17(1):e78045. doi: 10.7759/cureus.78045. PMID: 40013212; PMCID: PMC11862975. https://pmc.ncbi.nlm.nih.gov/articles/PMC11862975/
  12. Neuropathy and glutathione Cascinu S, Cordella L, Del Ferro E, Fronzoni M, Catalano G. Neuroprotective effect of reduced glutathione on cisplatin-based chemotherapy in advanced gastric cancer: a randomized double-blind placebo-controlled trial. J Clin Oncol. 1995 Jan;13(1):26-32. doi: 10.1200/JCO.1995.13.1.26. PMID: 7799029. https://pubmed.ncbi.nlm.nih.gov/7799029/
  13. Autoimmune conditions Perricone C, De Carolis C, Perricone R. Glutathione: a key player in autoimmunity. Autoimmun Rev. 2009 Jul;8(8):697-701. doi: 10.1016/j.autrev.2009.02.020. Epub 2009 Feb 13. PMID: 19393193. https://pubmed.ncbi.nlm.nih.gov/19393193/
  14. Hashimoto’s thyroiditis and glutatione: Rostami R, Aghasi MR, Mohammadi A, Nourooz-Zadeh J. Enhanced oxidative stress in Hashimoto’s thyroiditis: inter-relationships to biomarkers of thyroid function. Clin Biochem. 2013 Mar;46(4-5):308-12. doi: 10.1016/j.clinbiochem.2012.11.021. Epub 2012 Dec 4. PMID: 23219737. https://pubmed.ncbi.nlm.nih.gov/23219737/
  15. Rostami R, Nourooz-Zadeh S, Mohammadi A, Khalkhali HR, Ferns G, Nourooz-Zadeh J. Serum Selenium Status and Its Interrelationship with Serum Biomarkers of Thyroid Function and Antioxidant Defense in Hashimoto’s Thyroiditis. Antioxidants (Basel). 2020 Oct 31;9(11):1070. doi: 10.3390/antiox9111070. PMID: 33142736; PMCID: PMC7692168.https://pmc.ncbi.nlm.nih.gov/articles/PMC7692168/
  16. Alzheimer’s disease and memory: Mandal PK, Shukla D, Tripathi M, Ersland L. Cognitive Improvement with Glutathione Supplement in Alzheimer’s Disease: A Way Forward. J Alzheimers Dis. 2019;68(2):531-535. doi: 10.3233/JAD-181054. PMID: 30776003.https://pubmed.ncbi.nlm.nih.gov/30776003/
  17. Ulcerative Colitis: Kim JH, Ahn JB, Kim DH, Kim S, Ma HW, Che X, Seo DH, Kim TI, Kim WH, Cheon JH, Kim SW. Glutathione S-transferase theta 1 protects against colitis through goblet cell differentiation via interleukin-22. FASEB J. 2020 Feb;34(2):3289-3304. doi: 10.1096/fj.201902421R. Epub 2020 Jan 9. PMID: 31916636.https://pubmed.ncbi.nlm.nih.gov/31916636/
  18. Loguercio C, D’Argenio G, Delle Cave M, Cosenza V, Della Valle N, Mazzacca G, Del Vecchio Blanco C. Glutathione supplementation improves oxidative damage in experimental colitis. Dig Liver Dis. 2003 Sep;35(9):635-41. doi: 10.1016/s1590-8658(03)00379-7. PMID: 14563185.https://pubmed.ncbi.nlm.nih.gov/14563185/
  19. Crohns disease Miralles-Barrachina O, Savoye G, Belmonte-Zalar L, Hochain P, Ducrotté P, Hecketsweiler B, Lerebours E, Déchelotte P. Low levels of glutathione in endoscopic biopsies of patients with Crohn’s colitis: the role of malnutrition. Clin Nutr. 1999 Oct;18(5):313-7. doi: 10.1016/s0261-5614(98)80030-7. PMID: 10601540.https://pubmed.ncbi.nlm.nih.gov/10601540/
  20. Yanan Lv, Jian He, Jing Peng, Hao Li, Yayuan Yang, Zeyi Liang, Wenxiang Shen, Ghasem Hosseini Salekdeh, Xuezhi Ding, Gut microbiota-related glutathione metabolism is key mechanism for sulforaphane ameliorating ulcerative colitis,The Journal of Nutritional Biochemistry, Volume 146,2025,110042,ISSN 0955-2863, https://doi.org/10.1016/j.jnutbio.2025.110042 https://www.sciencedirect.com/science/article/abs/pii/S0955286325002050
  21. Peripheral artery disease Koutakis P, Ismaeel A, Farmer P, Purcell S, Smith RS, Eidson JL, Bohannon WT. Oxidative stress and antioxidant treatment in patients with peripheral artery disease. Physiol Rep. 2018 Apr;6(7):e13650. doi: 10.14814/phy2.13650. PMID: 29611350; PMCID: PMC5880878. https://pmc.ncbi.nlm.nih.gov/articles/PMC5880878/
  22. Lupus: Ravi N, Choday S, Shantha Kumar V, Kc A, Parisapogu A, Ojinna BT, Tran HH, Sherpa ML, Shrestha N, Mohammed L. The Key Role of Glutathione Compared to Curcumin in the Management of Systemic Lupus Erythematosus: A Systematic Review. Cureus. 2022 Nov 10;14(11):e31324. doi: 10.7759/cureus.31324. PMID: 36514656; PMCID: PMC9733821. https://pmc.ncbi.nlm.nih.gov/articles/PMC9733821/
  23. Parkinson’s disease Wang HL, Zhang J, Li YP, Dong L, Chen YZ. Potential use of glutathione as a treatment for Parkinson’s disease. Exp Ther Med. 2021 Feb;21(2):125. doi: 10.3892/etm.2020.9557. Epub 2020 Dec 4. PMID: 33376507; PMCID: PMC7751460. https://pmc.ncbi.nlm.nih.gov/articles/PMC7751460/
  24. Sechi G, Deledda MG, Bua G, Satta WM, Deiana GA, Pes GM, Rosati G. Reduced intravenous glutathione in the treatment of early Parkinson’s disease. Prog Neuropsychopharmacol Biol Psychiatry. 1996 Oct;20(7):1159-70. doi: 10.1016/s0278-5846(96)00103-0. PMID: 8938817.https://pubmed.ncbi.nlm.nih.gov/8938817/
  25. Glutathione and lung health Ghezzi P. Role of glutathione in immunity and inflammation in the lung. Int J Gen Med. 2011 Jan 25;4:105-13. doi: 10.2147/IJGM.S15618. PMID: 21403800; PMCID: PMC3048347.  https://pmc.ncbi.nlm.nih.gov/articles/PMC3048347/
  26. Glutathione reduces cancer risk: Kennedy L, Sandhu JK, Harper ME, Cuperlovic-Culf M. Role of Glutathione in Cancer: From Mechanisms to Therapies. Biomolecules. 2020 Oct 9;10(10):1429. doi: 10.3390/biom10101429. PMID: 33050144; PMCID: PMC7600400. https://pmc.ncbi.nlm.nih.gov/articles/PMC7600400/

One Response